Sanford Markowitz, MD, PhD
Sanford Markowitz, MD, PhD is a medical oncologist and colon cancer researcher at Case Western Reserve University, who is internationally recognized for his work identifying key genetic causes of colon cancer and developing molecular tests for early detection of this disease. Dr. Markowitz received his BA in chemistry and physics (summa cum laude) from Harvard University, and his MD and PhD (in cell biology) from Yale University. He performed his internship and residency in internal medicine at the University of Chicago, followed by a fellowship in medical oncology at the National Cancer Institute.
Dr. Markowitz is an Investigator of the Howard Hughes Medical Institute. Dr. Markowitz serves as head of the Cancer Genetics Program at the Ireland Cancer Center of University Hospitals of Cleveland, and also holds the Ingalls Professorship of Cancer Genetics at the Case Western Reserve University School of Medicine. A major new contribution from Dr. Markowitz is his development of a new molecular test for early detection of colon cancer. In March of 2008 the American Cancer Society (ACS) endorsed Dr. Markowitz's new colon cancer screening test as an alternative to colonoscopy, marking this as the first new test to win endorsement from the ACS since the development of PSA screening for prostate cancer.
Recognition of his contributions has included Dr. Markowitz's selection as a member of the scientific advisory boards of: the National Colon Cancer Research Alliance founded by Ms. Katie Couric, the Dana Farber/Harvard Cancer Center, and the Abramson Family Cancer Research Center of the University of Pennsylvania. Dr. Markowitz's research has been the subject of multiple articles in the lay press including the New York Times, the Wall Street Journal, Biography Magazine, and the Cleveland Plain Dealer.